Behavior Modification

Behavior Modification http://bmo.sagepub.
com/
The Timing of Exposure in Clinic-Based Treatment for Childhood Anxiety Disorders

Michelle R. Gryczkowski, Michael S. Tiede, Julie E. Dammann, Amy Brown Jacobsen, Lisa R. Hale and Stephen P. H. Whiteside Behav Modif 2013 37: 211 DOI: 10.1177/0145445513482394 The online version of this article can be found at: http://bmo.sagepub.com/content/37/2/211
Published by:
http://www.sagepublications.com
Additional services and information for Behavior Modification can be found at: Email Alerts: http://bmo.sagepub.com/cgi/alerts Subscriptions: http://bmo.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav Citations: http://bmo.sagepub.com/content/37/2/211.refs.html
>> Version of Record - Apr 2, 2013 What is This?
Downloaded from bmo.sagepub.com at Universiti Teknologi Malaysia on January 12, 2014
456546
94Behavior ModificationGryczkowski et al.
BMO37210.1177/01454455134823
The Timing of Exposure in Clinic-Based Treatment for Childhood Anxiety Disorders
Behavior Modification 37(2) 211225 The Author(s) 2013 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/0145445513482394 bmo.sagepub.com
Michelle R. Gryczkowski1, Michael S.Tiede1, Julie E. Dammann1, Amy Brown Jacobsen2,3, Lisa R. Hale2,3, and Stephen P. H. Whiteside1
Abstract The present study examines treatment length and timing of exposure from two child anxiety disorders clinics. Data regarding symptoms and treatment characteristics for 28 youth were prospectively obtained through self, parent, and therapist report at each session. Information regarding length of treatment, timing of exposure initiation, and drop-out rates were compared with those obtained through efficacy and effectiveness trials of manualized treatment for anxious youth. Findings from the authors clinical data revealed significantly shorter treatment duration with exposures implemented sooner than in the previous studies. Dropout rates were significantly higher than in the efficacy trial but comparable with the effectiveness trial. Outcome data from a subset of eight patients revealed large effect sizes.These findings suggest that effective treatment can be shorter and more focused on exposure than is often outlined in manuals and have important implications for outcome research and dissemination. Keywords external validity, evidence-based practice, exposures, children, anxiety, cognitive-behavioral therapy
1 2
Mayo Clinic, Rochester, MN, USA Kansas City Center for Anxiety Treatment, KS, USA 3 University of Missouri-Kansas City, MO, USA Corresponding Author: Stephen Whiteside, Department of Psychiatry and Psychology, Mayo Clinic, West 11, 200 First St., SW, Rochester, MN, 55905, USA. Email: Whiteside.Stephen@mayo.edu
212
Behavior Modification 37(2)
According to epidemiological data, anxiety disorders are among the most common childhood mental health diagnoses (Merikangas & Avenevoli, 2002) with lifetime prevalence rates ranging from 6% to 15% (Silverman & Ginsburg, 1998; U.S. Public Health Service, 2000). Anxiety disorders cause substantial impairment across a variety of domains of functioning (e.g., academic, social, familial); are highly comorbid with other anxiety, emotional, and behavioral disorders; and often persist into adulthood (Anderson, 1994; Chorpita & Southam-Gerow, 2006; Mendlowicz & Stein, 2000; Quilty, Van Ameringen, Mancini, Oakman, & Farvolden, 2003). Cognitivebehavioral therapy (CBT) is an efficacious treatment for childhood anxiety disorders (Compton et al., 2010); however, the need for increased focus on external validity through effectiveness studies has recently been emphasized, particularly given meta-analytic findings that treatments deemed efficacious may not hold up in effectiveness trials (Chorpita et al., 2011; Weisz, Donenberg, Han, & Weiss, 1995; Weisz & Jensen, 2001). Such findings (or lack thereof) call into question the transportability of manualized treatment to clinical practice. The treatment manual most widely used in randomized controlled trials (RCTs) of childhood anxiety treatment is the Coping Cat (CC; Kendall, 2000). This empirically supported treatment is currently the gold standard protocol for treating anxious youth. It prescribes 16 to 20 sessions, the first half of which focuses on psychoeducation, emotional awareness, relaxation, and cognitive restructuring, whereas the latter half focuses on facing fears through exposures. In a recent RCT conducted by Walkup and colleagues (2008) comparing CBT, sertraline, and their combination to a pill placebo, a condensed 12-session version of CC was found to be superior to placebo but less effective than combined treatment. However, in two recent effectiveness studies (Barrington, Prior, Richardson, & Allen, 2005; Southam-Gerow et al., 2010), CC failed to demonstrate superiority over usual care with respect to percentage of youth no longer meeting criteria for an anxiety disorder. Southam-Gerow and colleagues commented on the fact that only 54.2% of the youth in the CBT condition received the full 16 sessions and only 58% received exposure therapy, which is thought to be central to anxiety disorder treatment (Chorpita & Southam-Gerow, 2006; Davis & Ollendick, 2005; Kendall et al., 2005; Silverman & Kurtines, 1996). Thus, it is possible that the CBT group would have demonstrated greater effects had more of the youth received exposure or a larger dose of it. In contrast to CC, other researchers have emphasized the use of exposure earlier in treatment and de-emphasized the use of other anxiety management techniques. For example, a multiple baseline study provides initial support
Gryczkowski et al.
213
for the efficacy of a modular approach that reviews psychoeducation and constructs a fear hierarchy before initiating exposures (Chorpita, 2007; Chorpita, Taylor, Francis, Moffitt, & Austin, 2004). A retrospective examination of outpatient treatment of child anxiety disorders consistent with the modularized approach found that when exposures were initiated by approximately the third session, large treatment effect sizes could be obtained in roughly half the sessions of CC (Vande Voort, Svecova, Brown Jacobsen, & Whiteside, 2010). Moreover, they found that the more time the clinician dedicated to anxiety management strategies such as cognitive techniques, the less time was spent on exposures. This finding was particularly important, as the number of exposures correlated positively with improvements in functioning, whereas the use of other anxiety management techniques correlated negatively with this outcome. The authors concluded that a shorter and more flexible treatment approach than what is prescribed in manuals for anxiety disorders can be effective for at least some children. Although Vande Voort and colleagues (2010) demonstrated that it is possible to effect improvement with shorter, more exposure-focused treatment, the degree to which these patients are representative of children with anxiety disorders is unknown because the sample was restricted to treatment completers. Specifically, it is possible that the patients in the study were atypically receptive to exposures and that many other patients dropped out of treatment because they either found it unacceptable or did not respond effectively and were subsequently excluded from the sample. The current study was designed to build on the previous findings by prospectively examining the course of clinic-based treatment for childhood anxiety disorders. This methodology allowed for examination of treatment adherence, more accurate documentation of treatment components, and collection of symptom data throughout the intervention. We hypothesized that (a) treatment will, on average, consist of fewer sessions and implement exposure earlier than recommended in treatment manuals, (b) a greater percentage of patients will receive exposure therapy than has been achieved in effectiveness trials of manualized treatment, and (c) dropout rates will be similar to those in effectiveness trials.
Method Participants
Data regarding 28 consecutive child patients (17 male, 60.7%) ranging in age from 6 to 18 years (M = 10.89, SD = 3.53) seen in two outpatient clinics for
214
an anxiety disorder were collected under an Institutional Review Board (IRB)-approved protocol. The majority of children were Caucasian (82.1%; 3.6% African American, 14.3% unidentified). Parents were predominately married and had some postsecondary education. A doctoral level clinical psychologist, supervised masters level clinician, or child psychiatrist made diagnoses after an evaluation as part of regular clinical practice. Diagnoses were determined for all patients consistent with the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR; American Psychiatric Association, 2000). The majority of the patients had a primary anxiety disorder (27, 96.4%), although many had multiple diagnoses (14, 40%). The most common anxiety diagnosis was obsessive-compulsive disorder (OCD; 25%), followed by separation and generalized anxiety disorders (17.9% each).
Treatment
Treatment was provided by one of five therapists within the two programs: three licensed doctoral level clinical psychologists specializing in the treatment of childhood anxiety disorders and two masters level therapists supervised by one of the psychologists. All therapists had detailed knowledge of and experience using treatment manuals (i.e., Chorpita, 2007; Kendall, 2000) and provided CBT, including exposures. The treatment approach was consistent with Chorpitas modularized approach.
Data Collection
As part of the standard assessment procedure in the anxiety disorders clinics, all children and their parent(s) completed a variety of questionnaires, including a demographic form and standardized measures assessing anxiety symptom severity, functional impairment, and various additional measures not used in the present study. Beginning at the first treatment session following the assessment, the child, a parent, and the therapist completed a data entry form. All patients with a primary anxiety disorder were eligible; one family did not allow data to be used for research purposes and was excluded. The child and a parent completed a questionnaire at the beginning of each session that included idiographic questions about symptom severity and impairment. At the end of each session, the therapist recorded the treatment techniques (e.g., relaxation, cognitive restructuring, exposure) that had been implemented during the session. The reliability of clinician ratings for
Gryczkowski et al.
215
implementation of exposure was examined for 25% of patients by a trained assistant through a retrospective chart review using the procedure from a previous study (Vande Voort et al., 2010). The agreement level between the rater and the therapist was 84.8%, demonstrating good reliability. Data collection continued until the treatment of the presenting anxiety complaint was completed or the patient dropped out of therapy. Information regarding the final disposition was gathered through a chart review with a patient considered a dropout if the last session attended did not include a discussion of having met treatment goals and agreement among the clinician, child, and parent(s) that further treatment was not necessary. Additional sessions for other presenting complaints (i.e., adjustment issues) or booster sessions were not included in the present analyses.
Measures
Spence Childrens Anxiety Scale (SCAS). The SCAS (Spence, 1998) is a Likerttype measure ranging from 0 (never) to 3 (always) of anxiety symptoms completed by the child (45 items) or parent (SCAS-P, 38 items; Nauta et al., 2004). Although the SCAS-P has six basic scales, only the total score was included in the present study. High internal consistency and validity data have been demonstrated for the SCAS, including group differences between clinical versus nonclinical samples, convergent validity with other anxiety measures, and discriminant validity with measures of depression (Muris, Merckelbach, Ollendick, King, & Bogie, 2002; Muris, Schmidt, & Merckelbach, 2000; Spence, 1998). Similar support demonstrating internal consistency, parentchild agreement, as well as convergent and discriminant validity also exists for the SCAS-P (Nauta et al., 2004). The internal consistency in the current sample for the SCAS and SCAS-P were .87 and .91, respectively. Child Sheehan Disability Scale (CSDS). The CSDS (Whiteside, 2009) measures the extent to which a childs anxiety symptoms interfere with daily functioning. The CSDS is an adaptation of the Sheehan Disability Scale (SDS; Sheehan, 1986) and consists of items inquiring about the degree to which the childs anxiety symptoms interfere with school, social, and family functioning. As on the SDS, items are measured on an 11-point Likert-type scale ranging from 0 (not at all) to 10 (very, very much). A 5-item parent version (CSDS-P) assesses the degree to which the parent perceives the childs anxiety symptoms to be interfering with the childs, as well as the parents, school/work, social, and family functioning.
216
Idiographic Anxiety Questionnaire

The child and a parent provided ratings of anxiety severity and impairment at each session. At the initial appointment, the therapist worked with the child and parent to identify the childs primary anxiety symptom. The child and parent then rated the severity of that symptom and the degree to which that symptom interfered with functioning on an 11-point Likert-type scale ranging from 0 (not at all) to 10 (extremely). At each subsequent session, the parent and child rated the severity of the childs anxiety symptoms and associated impairment since the last visit.
Analyses
The characteristics of treatment were benchmarked against two studies that represent state of the art research on the gold standard manualized treatment, CC, in terms of efficacy (Child/Adolescent Anxiety Multimodal Study; CAMS; Compton et al., 2010; Walkup et al., 2008) and effectiveness (ES; Southam-Gerow et al., 2010). Single-sample t-tests were used to compare the number of sessions, the session in which exposure exercises were begun, and rate of attrition in the current sample with the previous studies. To examine treatment outcome, paired-samples t-tests were used to compare symptom and interference ratings at the first session with those gathered at the final session within a subsample of patients with complete data.
Results Baseline Data

At baseline, the intent-to-treat (ITT) sample of children had mean anxiety severity levels in the moderate range, as measured by the SCAS parent (M = 31.09, SD = 12.58) and child (M = 33.39, SD = 12.41) reports. Functional impairment scores, as measured by the CSDS, were similar to previously reported clinical scores (Whiteside, 2009; M = 12.33, SD = 7.50 for child report; M = 19.43, SD = 12.62 for parent report).
Treatment Descriptions
The length of treatment for anxiety disorders ranged from 1 to 32 sessions with an average of 7.89 (SD = 5.9) sessions, which is significantly less than the 12-session protocol in the CAMS, t(27) = 3.71, p = .001, and the
Gryczkowski et al.
217
14-session mean treatment length in the ES, t(27) = 5.52, p < .001. The median and modal number of sessions was 6, and 53.4% of patients attended 6 or fewer sessions. Information regarding the session in which exposures were first implemented was available for 25 patients. All received exposure therapysignificantly more than the 58% who received exposure therapy in the ES, binomial test (24), p < .001. In addition, the mean session number in which exposures began in the clinic, 1.92 (SD = .91), was significantly sooner than in the CAMS study (Session 7), t(24) = 27.94, p < .001, with all patients beginning exposures by the fourth session. Given that exposures are typically prescribed earlier in manuals for OCD than other anxiety disorders, the session in which exposure was initiated was examined separately for patients with (n = 7) and without OCD (n = 18). The mean session in which exposure was initiated did not differ between the OCD (2.29; SD = 1.11) and non-OCD (1.78; SD = 0.81) patients, t(23) = 1.27, p = .217.
Treatment Dropouts
Of the initial 28 patients, 16 (57.1%) successfully completed treatment based on chart review. This completion rate is significantly lower than the 95.7% in the CAMS study, binomial test (27), p < .001, and not significantly different from the rate of 54.2% receiving the full 16 sessions in the ES, binomial test (27), p = .453.
Treatment Outcome
Outcome analyses were completed with the eight patients for whom complete session-by-session data were available. Figure 1 presents mean childand parent-reported idiographic anxiety and interference ratings at each session. The effectiveness of treatment was analyzed through paired-sample t-tests comparing pre- and post-treatment idiographic anxiety and interference ratings. Significant prepost reductions were found for parent-reported anxiety ratings (pre = 6.88 [2.64], post = 2.75 [1.49]), t(7) = 3.78, p = .007, and interference ratings (pre = 5.75 [3.33], post = 1.75 [1.04]), t(7) = 3.23, p = .014, and for child-reported anxiety ratings (pre = 6.25 [4.13], post = 2.00 [2.27]), t(7) = 3.19, p = .015. The reduction in mean child-reported idiographic interference ratings was not significant (pre = 4.13 [3.87], post = 1.63 [1.69]), t(7) = 1.93, p = .095. Consistent with the CAMS, effect sizes were computed using Hedgess g, which is bias corrected and more appropriate for small sample sizes (Grissom & Kim, 2005). These effect sizes, as well
218
Figure 1. Graph of mean idiographic anxiety and interference ratings at each session.
as the effect sizes found in previous RCTs, are presented in Table 1. Cohen (1977) suggested that effect size magnitudes of 0.20, 0.50, and 0.80 correspond to small, medium, and large effects, respectively.
Discussion
This study compared exposure-focused treatment with efficacy and effectiveness trials of manualized intervention for childhood anxiety disorders (Southam-Gerow et al., 2010; Walkup et al., 2008). Similar to a previous examination (Vande Voort et al., 2010), we found that treatment introducing exposures earlier and consisting of fewer sessions than CC was effective in reducing anxiety symptoms and associated impairment. Moreover, although attrition was substantially greater than that found in a well-controlled efficacy trial, it was similar to rates in an effectiveness study. In addition, significantly more patients received at least an introduction to exposure therapy in the current sample compared with clinic-based CC. Therefore, introducing exposures early in treatment does not necessarily lead to higher attrition and
Gryczkowski et al.
Table 1. Treatment Effect Sizes (Hedgess g) Across Studies. Present study Source Parent Self Clinician Combined Anxiety 1.82 1.41 Interference 1.24 0.79 CAMS PARS 1.62 CGI 1.61
219
Effectiveness Coping Cat RCT original STAIC-T 0.44 0.27 STAIC-T 0.73 1.47
Note: CAMS = Child/Adolescent Anxiety Multimodal Study; RCT = randomized controlled trial; PARS = Pediatric Anxiety Rating Scale. CGI = Clinical Global ImpressionSeverity scale. STAIC-T = State-Trait Anxiety Inventory for ChildrenTrait Version. In present study, effect sizes are calculated from mean differences in idiographic anxiety severity and interference measures. Combined scores = self + parent report.
has the potential to improve clinic outcomes by increasing the number of patients introduced to exposure. The current results raise the possibility that exposure exercises can be introduced into treatment earlier than what is prescribed in the most heavily researched treatment manual. Although most protocols include the use of exposure, this technique is often instituted after multiple sessions spent introducing alternative anxiety coping strategies (e.g., relaxation, cognitive restructuring). The inclusion of these strategies is designed to directly reduce symptoms, increase engagement in treatment, and facilitate maintenance of gains. In contrast, there is some evidence to suggest that breathing retraining, relaxation, and cognitive coping are either unnecessary or related to poorer outcomes (Craske & Barlow, 2008; Deacon & Abramowitz, 2004; Vande Voort et al., 2010). The similar levels of attrition and the large treatment effect sizes associated with exposure-focused treatment relative to CC administered in a clinical setting do not support the assumption that additional anxiety coping strategies must precede the introduction of exposure exercises. As such, these findings highlight the need for dismantling studies to determine the extent to which nonexposure anxiety management techniques are necessary. Determining the appropriate combination of treatment components and order in which they are implemented has important implications for improving interventions for children with anxiety disorders. To begin with, exposure exercises are thought to be a key component in the treatment of anxiety disorders and may be the primary mechanism of change (Beidel, Turner, & Morris, 2000; Davis & Ollendick, 2005; Kendall et al., 2005; Salcioglu,
220
Basoglu, & Livanou, 2007; Silverman & Kurtines, 1996). The fact that more than half of the patients in the current study and the comparison effectiveness trial (Southam-Gerow et al., 2010) discontinued treatment before the session in which exposures are recommended to begin in CC suggests that many children will not receive the most important treatment component even if they receive treatment consistent with the most recent research. Alternatively, although it may not be essential to begin with nonexposure techniques, they may increase acceptability of exposures among patients who are treatment resistant or provide patients with more skills to handle future anxiety problems. To be sure, more research is needed to clarify the role of such techniques. The current findings may also have implications for improving the dissemination of effective treatments. The fact that few clinicians who describe their therapeutic orientation as cognitive behavioral actually use exposure regularly when treating anxiety disorders is concerning (Freiheit, Vye, Swan, & Cady, 2004; Goisman et al., 1993; Valderhaug, Gotestam, & Larsson, 2004). Lack of knowledge, lack of adequate training in exposure therapy, fear of patient dropout, ease of administration of alternative techniques, and clinician discomfort with inducing anxiety in their patients are all potential explanations for why exposure is infrequently being implemented. Thus, more education and a greater emphasis on exposures in treatment manuals are necessary. As previously discussed by Vande Voort and colleagues (2010), the low rate of empirically based treatment in clinical practice should not be solely attributed to therapist factors as there appears to be some merit to clinician concerns that manualized treatments are too long and inflexible (Addis, 2002). These views are further supported by the fact that many patients may achieve significant symptom relief in 6 to 10 sessions without receiving all prescribed treatment components. An approach that begins with exposures and has the flexibility to add additional techniques as needed (e.g., Chorpita, 2007) may not only be more acceptable to clinicians, it may also be more effective and cost-efficient in clinical settings. The present study is not without its limitations. To begin with, the current study was based on a small sample size and needs to be replicated in a larger, more diverse sample. Second, the diagnoses were not based on a structured interview, which raises the possibility that the current sample differed from the previous trials in important ways, such as in symptom severity. However, the intention of this line of research is to inform the development of evidencebased treatment from a clinical perspective. As such, the current sample likely bears a close resemblance to patients seen by practitioners in outpatient clinics who are the targets of dissemination. Third, because the current study
Gryczkowski et al.
221
was descriptive and lacked a comparison group, it is not possible to weigh the relative merits of different approaches to treatment. However, the current design is sufficient to support the appropriateness of an exposure-focused condition in dismantling studies. Despite these limitations, the current study suggests that treatment manuals focusing more directly on exposure have the potential to maintain efficacy without decreasing acceptability and effectiveness. Perhaps one of the most pressing issues facing the field of child anxiety disorders is the determination of essential and nonessential treatment components (Kazdin & Nock, 2003). The development of more effective and cost-efficient treatments has the potential to improve efforts toward dissemination and reduce the gap between effect sizes found in effectiveness and efficacy trials (Barrington et al., 2005; Chorpita et al., 2011; Southam-Gerow et al., 2010; Weisz et al., 1995). Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
References
Addis, M. E. (2002). Methods for disseminating research products and increasing evidence-based practice: Promises, obstacles, and future directions. Clinical Psychology: Science and Practice, 9, 367-378. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author. Anderson, J. C. (1994). Epidemiological issues. In T. H. Ollendick, N. J. King, & W. Yule (Eds.), International handbook or phobic and anxiety disorders in children and adolescents (pp. 43-65). New York, NY: Plenum. Barrington, J. W., Prior, M., Richardson, M., & Allen, K. (2005). Effectiveness of CBT versus standard treatment for childhood anxiety disorders in a community clinic setting. Behavior Change, 22, 29-43. Beidel, D. C., Turner, S. M., & Morris, T. L. (2000). Behavioral treatment of childhood social phobia. Journal of Consulting and Clinical Psychology, 68, 1072-1080. Chorpita, B. F. (2007). Modular cognitive-behavioral therapy for childhood anxiety disorders. New York, NY: Guilford.
222
Chorpita, B. F., Daleiden, E. L., Ebesutani, C., Young, J., Becker, K. D., Nakamura, B. J., . . . Starace, N. (2011). Evidence-based treatments for children and adolescents: An updated review of indicators of efficacy and effectiveness. Clinical Psychology Science and Practice, 18, 154-172. Chorpita, B. F., & Southam-Gerow, M. A. (2006). Fears and anxieties. In E. J. Mash & R. A. Barkley (Eds.), Treatment of child disorders (3rd ed., pp. 271-335). New York, NY: Guilford. Chorpita, B. F., Taylor, A. A., Francis, S. E., Moffitt, C., & Austin, A. A. (2004). Efficacy of modular cognitive behavior therapy for childhood anxiety disorders. Behavior Therapy, 35, 263-287. Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York, NY: Academic Press. Compton, S. N., Walkup, J. T., Albano, A. M., Piacentini, J. C., Birmaher, B., Sherrill, J. T., . . . March, J. S. (2010). Child/Adolescent Anxiety Multimodal Study (CAMS): Rationale, design, and methods. Child and Adolescent Psychiatry and Mental Health, 4, 1. Craske, M., & Barlow, D. (2008). Panic disorder and agoraphobia. In D. Barlow (Ed.), Clinical handbook of psychological disorders (4th ed., pp. 1-64). New York, NY: Guilford. Davis, T. E., III, & Ollendick, T. H. (2005). Empirically supported treatments for specific Phobia in children: Do efficacious treatments address the components of a phobic response? Clinical Psychology: Science and Practice, 12, 144-160. Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60, 429-441. Freiheit, S. R., Vye, C., Swan, R., & Cady, M. (2004). Cognitive behavioral therapy for anxiety: Is dissemination working? Behavior Therapist, 27, 25-32. Goisman, R. M., Rogers, M. P., Steketee, G. S., Warshaw, M. G., Cuneo, P., & Keller, M. B. (1993). Utilization of behavioral methods in a multicenter anxiety disorders study. Journal of Clinical Psychiatry, 54, 213-218. Grissom, R. J., & Kim, J. J. (2005). Effect sizes for research: A broad practical approach. New York, NY: Lawrence Erlbaum. Kazdin, A. E., & Nock, M. K. (2003). Delineating mechanisms of change in child and adolescent therapy: Methodological issues and research recommendations. Journal of Child Psychology and Psychiatry, 44, 1116-1129. Kendall, P. C. (2000). Cognitive-behavioral therapy for anxious children: Therapist manual (2nd ed.). Ardmore, PA: Workbook Publishing. Kendall, P. C., Robin, J. A., Hedtke, K. A., Suveg, C., Flannery-Schroeder, E., & Gosch, E. (2005). Considering CBT with anxious youth? Think exposures. Cognitive and Behavioral Practice, 12, 136-150.
Gryczkowski et al.
223
Mendlowicz, M. V., & Stein, M. B. (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry, 157, 669-682. Merikangas, K. R., & Avenevoli, S. (2002). Epidemiology of mood and anxiety disorders in children and adolescents. In M. T. Tsuang & M. Tohen (Eds.), Textbook in psychiatric epidemiology (2nd ed.) (pp.657-704). New York, NY: Wiley-Liss. Muris, P., Merckelbach, H., Ollendick, T., King, N., & Bogie, N. (2002). Three traditional and three new childhood anxiety questionnaires: Their reliability and validity in a normal adolescent sample. Behaviour Research and Therapy, 40, 753-772. Muris, P., Schmidt, H., & Merckelbach, H. (2000). Correlations among two selfreport questionnaires for measuring DSM-defined anxiety disorder symptoms in children: The screen for child anxiety related emotional disorders and the Spence Childrens Anxiety Scale. Personality and Individual Differences, 28, 333-346. Nauta, M. H., Scholing, A., Rapee, R. M., Abbott, M., Spence, S. H., & Waters, A. (2004). A parent-report measure of childrens anxiety: Psychometric properties and comparison with child-report in a clinic and normal sample. Behaviour Research and Therapy, 42, 813-839. Quilty, L. C., Van Ameringen, M., Mancini, C., Oakman, J., & Farvolden, P. (2003). Quality of life and the anxiety disorders. Journal of Anxiety Disorders, 17, 405-426. Salcioglu, E., Basoglu, M., & Livanou, M. (2007). Effects of live exposure on symptoms of posttraumatic stress disorder: The role of reduced behavioral avoidance in improvement. Behavior Research and Therapy, 45, 2268-2279. Sheehan, D. V. (1986). The anxiety disease. New York, NY: Bantam Books. Silverman, W. K., & Ginsburg, G. (1998). Anxiety disorders. In T. Ollendick & H. Hersen (Eds.), Handbook of child psychopathology (pp. 239-268). New York, NY: Plenum. Silverman, W. K., & Kurtines, W. M. (1996). Transfer of control: A psychosocial intervention model for internalizing disorders in youth. In E. D. Hibbs & P. S. Jensen (Eds.), Psychosocial treatments for child and adolescent disorders: Empirically based strategies for clinical practice (pp. 63-81). Washington, DC: American Psychological Association. Southam-Gerow, M. A., Weisz, J. R., Chu, B. C., McLeod, B. D., Gordis, E. B., & Connor-Smith, J. K. (2010). Does cognitive behavioral therapy for youth anxiety outperform usual care in community clinics? An initial effectiveness test. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 1043-1052. Spence, S. H. (1998). A measure of anxiety symptoms among children. Behaviour Research and Therapy, 36, 545-566. U.S. Public Health Service. (2000). Report of the Surgeon Generals Conference on Childrens Mental Health: A National Action Agenda. Washington, DC: Department of Health and Human Services.
224
Valderhaug, R., Gotestam, K. G., & Larsson, B. (2004). Clinicians views on management of obsessive-compulsive disorders in children and adolescents. Nordic Journal of Psychiatry, 58, 125-132. Vande Voort, J. L., Svecova, J., Brown Jacobsen, A., & Whiteside, S. P. (2010). A retrospective examination of the similarity between clinical practice and manualized treatment of childhood anxiety disorders. Cognitive and Behavioral Practice, 17, 322-328. Walkup, J. T., Albano, A. M., Piacentini, J. C., Birmaher, B., Compton, S. N., Sherrill, J. T., . . . Kendall, P. C. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753-2766. Weisz, J. R., Donenberg, G. R., Han, S. S., & Weiss, B. (1995). Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. Journal of Consulting and Clinical Psychology, 63, 688-701. Weisz, J. R., & Jensen, A. L. (2001). Child and adolescent psychotherapy in research and practice contexts: Review of the evidence and suggestions for improving the field. European Child and Adolescent Psychiatry, 10, I12-I18. Whiteside, S. P. (2009). Adapting the Sheehan Disability Scale to assess child and parent impairment related to childhood anxiety disorders. Journal of Clinical Child and Adolescent Psychology, 38, 721-730.
Author Biographies
Michelle R. Gryczkowski is a postdoctoral fellow in Child Clinical Psychology at Mayo Clinic in Rochester, MN and specializes in child anxiety disorders. Her research interests include treatment of childhood anxiety disorders and parenting in relation to child anxiety and externalizing disorders. Michael S. Tiede is a Masters level psychologist at Mayo Clinic in Rochester, MN. He is the coordinator of the Pediatric Anxiety Disorder Clinic and provides a variety of mental health services to children, adolescents, and their families. Julie E. Dammann is a Masters level psychologist at Mayo Clinic in Rochester, MN. She is a clinician in the Pediatric Anxiety Disorder Clinic and provides a variety of mental health services to children, adolescents, and their families. Amy Brown Jacobsen is a CBT/ERP Specialist at Kansas City Center for Anxiety Treatment and an Adjunct Associate Professor in the Department of Psychology at the University of Missouri-Kansas City. Her research interests include the role of the family environment in anxiety disorders and the development of intervention programs for children and families affected by anxiety.
Gryczkowski et al.
225
Lisa R. Hale is the founder and director of Kansas City Center for Anxiety Treatment and an Adjunct Associate Professor in the Department of Psychology at the University of Missouri-Kansas City. She is a strong advocate for education surrounding evidence-based treatment and increasing access to quality care. Her research interests include the identification of cognitive risk factors for anxiety disorders and issues of treatment dissemination and adherence across neuropsychiatric and behavioral health conditions. Stephen P. H. Whiteside is an Associate Professor of Psychology and director of the Pediatric Anxiety Disorder Clinic at Mayo Clinic in Rochester, MN. His research interests include the assessment and treatment of child and adolescent on anxiety disorders. Previous and ongoing projects include using neuroimaging to evaluate the effectiveness of psychological treatments for OCD, developing assessment procedures for anxiety, and developing intensive treatments for OCD and other anxiety disorders.
Publishers Note:
This article was inadvertently published in Behavior Modification 37(1), 113-127. Same article has been reprinted as part of this special issue.

Behavior Modification

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Behavior Modification

Hochgeladen von

Copyright:

Verfügbare Formate

Behavior Modification http://bmo.sagepub.

The Timing of Exposure in Clinic-Based Treatment for Childhood Anxiety Disorders

>> Version of Record - Apr 2, 2013 What is This?

Downloaded from bmo.sagepub.com at Universiti Teknologi Malaysia on January 12, 2014

The Timing of Exposure in Clinic-Based Treatment for Childhood Anxiety Disorders

Downloaded from bmo.sagepub.com at Universiti Teknologi Malaysia on January 12, 2014